Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

NCT04734548 is registered in ClinicalTrials.gov with aptaTargets S.L. as lead sponsor.

NCT NCT04734548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04734548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
Lead sponsor
aptaTargets S.L.
Phase
Phase 1/2
Overall status
Completed
Start date
October 28, 2020
Completion date
September 7, 2022
Enrollment
151 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, ischemic stroke, stroke